Experimental autoimmune thyroiditis in nonobese diabetic mice lacking interferon regulatory factor-1

Area of Science:

• Immunology
• Endocrinology
• Autoimmunity

Background:

• Interferon regulatory factor-1 (IRF-1) plays a key role in interferon-mediated immune responses.
• IRF-1 is implicated in the pathogenesis of autoimmune diseases.
• Experimental autoimmune thyroiditis (EAT) in nonobese diabetic (NOD) mice serves as a model for Hashimoto's thyroiditis (HT).

Purpose of the Study:

• To investigate the requirement of IRF-1 in the development of EAT in NOD mice.
• To determine if IRF-1 deficiency impacts autoimmune thyroiditis development.

Main Methods:

• NOD mice with varying IRF-1 genotypes (+/+, +/-, -/-) were immunized with mouse thyroglobulin (mTg).
• Development of EAT and anti-mTg antibodies were assessed.
• Thyroid and spleen immune cell populations (CD4+, CD8+ T cells) and cytokine production (IFN-gamma) were analyzed.

Main Results:

• IRF-1-deficient mice developed EAT and anti-mTg antibodies comparable to wild-type and heterozygous mice.
• CD8+ T cells were absent in the thyroids of IRF-1-/- mice, unlike in IRF-1+/+ mice.
• Major histocompatibility complex class II expression was similar in thyroids of IRF-1+/+ and -/- mice.
• IRF-1 deficiency led to reduced splenic CD8+ T cell numbers and decreased IFN-gamma production.

Conclusions:

• IRF-1 is not pivotal in the development of EAT in NOD mice.
• While IRF-1 influences CD8+ T cell populations and IFN-gamma production, its absence does not abrogate EAT.
• These findings suggest a complex regulatory role for IRF-1 in autoimmune thyroiditis.